Age: 36
Free Agency: 2024 (Void)
Accrued Seasons: 11
- Height: 6'2"
- Weight: 200
- College: Florida State
- Entry: 2009 Undrafted Free Agent (Ravens)
- 2023 Salary Cap Charge: $5,547,963 (2.43% of cap)
- 2023 Cash Payout: $3,750,000 (1.41% of spending)
- 2023 Cash to Cap Ratio: 0.68
- Contract Value: $14,000,000 ($4,666,667 APY)
- Fully Guaranteed Money: $9,500,000
- Contract Ranking: 7/47 at K
Current Contract
(Extension, signed 2020)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Roster Bonus | Per Game Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 33 | $1,750,000 | $1,000,000 | $0 | $250,000 | $0 | $2,906,250 | 1.5% | |||||
| 2021 | 34 | $1,486,111 | $921,296 | $1,500,000 | $0 | $2,986,111 | $3,907,407 | 2.1% | |||||
| 2022 | 35 | $1,120,000 | $1,797,962 | $0 | $0 | $0 | $2,917,962 | 1.4% | |||||
| 2023 | 36 | $3,750,000 | $1,797,963 | $0 | $0 | $0 | $5,547,963 | 2.4% | |||||
| 2024 | 37 | Void | $876,668 | Void | Void | Void | $876,668 | 0.3% | |||||
| Total | $8,106,111 | $6,393,889 | $1,500,000 | $250,000 | $2,986,111 | $16,156,250 | |||||||
Contract Notes
K Graham Gano signed a three year, $14 million contract extension with the Giants. Gano received a $3 million signing bonus and $9.5 million in guarantees.
Cash Flows
- fully earned money
- unearned or partially earned money
$4.7M
$9.3M
$14M
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Cash Due | $3,000,000 | $3,500,000 | $3,750,000 | $3,750,000 |
| Running Cash | $3,000,000 | $6,500,000 | $10,250,000 | $14,000,000 |
Career Earnings: $36,630,000
Career APY: $3,330,000
Potential Earnings: $40,330,000
Total Guarantees: $22,450,000
Largest Cash Payment: $8,050,000 (2018)
Largest Cap Number: $5,547,963 (2023)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Panthers | UFA | Expired | 2014 | 4 | $12,400,000 | $3,100,000 | $3,950,000 | $12,700,000 | 102.4% | $3,175,000 |
| Panthers | UFA | Terminated | 2018 | 4 | $17,000,000 | $4,250,000 | $8,000,000 | $10,050,000 | 59.1% | $5,025,000 |
| Giants | SFA | Renegotiated | 2020 | 1 | $2,250,000 | $2,250,000 | $1,000,000 | $0 | 0.0% | $0 |
| Giants | Extension | Active | 2020 | 3 | $14,000,000 | $4,666,667 | $9,500,000 | $12,500,000 | 89.3% | $4,166,667 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Panthers | 8 | $24,130,000 | $3,016,250 | $21,155,000 | 0.0% | $3,125,000 | 0.0% |
| Giants | 3 | $12,500,000 | $4,166,667 | $9,731,619 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Per Game Roster Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | Panthers | $615,000 | $0 | $0 | $0 | $0 | $0 | $615,000 | 0.5% | $615,000 | ||
| 2013 | Panthers | $715,000 | $0 | $0 | $0 | $0 | $0 | $715,000 | 0.6% | $715,000 | ||
| 2014 | Panthers | $950,000 | $750,000 | $0 | $0 | $50,000 | $950,000 | $1,750,000 | 1.3% | $4,000,000 | ||
| 2015 | Panthers | $2,300,000 | $750,000 | $0 | $0 | $50,000 | $0 | $3,100,000 | 2.1% | $2,350,000 | ||
| 2016 | Panthers | $3,050,000 | $750,000 | $0 | $0 | $50,000 | $0 | $3,850,000 | 2.5% | $3,100,000 | ||
| 2017 | Panthers | $3,200,000 | $750,000 | $0 | $0 | $50,000 | $0 | $4,000,000 | 2.2% | $3,250,000 | ||
| 2018 | Panthers | $1,850,000 | $1,537,500 | $0 | $0 | $50,000 | $1,850,000 | $3,437,500 | 1.9% | $8,050,000 | ||
| 2019 | Panthers | $1,950,000 | $1,537,500 | $0 | $200,000 | $50,000 | $1,000,000 | $3,687,500 | 1.9% | $2,000,000 | ||
| 2020 | Giants | $1,750,000 | $1,000,000 | $0 | $250,000 | $0 | $0 | $2,906,250 | 1.5% | $5,250,000 | ||
| 2021 | Giants | $1,486,111 | $921,296 | $1,500,000 | $0 | $0 | $2,986,111 | $3,907,407 | 2.1% | $3,500,000 | ||
| 2022 | Giants | $1,120,000 | $1,797,962 | $0 | $0 | $0 | $0 | $2,917,962 | 1.4% | $3,750,000 | ||
| 2023 | Giants | $3,750,000 | $1,797,963 | $0 | $0 | $0 | $0 | $5,547,963 | 2.4% | $3,750,000 | ||
| 2024 | Giants | $0 | $876,668 | $0 | $0 | $0 | $0 | $876,668 | 0.3% | $0 | ||
| Total | $22,736,111 | $12,468,889 | $1,500,000 | $450,000 | $300,000 | $6,786,111 | $37,311,250 | $40,330,000 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | Field Goals | PAT | Points | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Special | Made | Att. | Blk. | Long | Made | Att. | Blk. | |||
| 2012 | 6 | -- | -- | 15.1% | 9 | 11 | 0 | 51 | 20 | 21 | 0 | 47 |
| 2013 | 16 | 0 | 0 | 30.8% | 24 | 27 | 1 | 55 | 42 | 42 | 0 | 114 |
| 2014 | 16 | 0 | 0 | 33.3% | 29 | 35 | 1 | 53 | 34 | 34 | 0 | 121 |
| 2015 | 16 | 0 | 0 | 38.9% | 30 | 36 | 4 | 52 | 56 | 59 | 1 | 146 |
| 2016 | 16 | 0 | 0 | 34.3% | 30 | 38 | 0 | 54 | 31 | 34 | 2 | 121 |
| 2017 | 16 | 0 | 0 | 32.5% | 29 | 30 | 0 | 48 | 34 | 37 | 1 | 121 |
| 2018 | 12 | 4 | 0 | 24.9% | 14 | 16 | 0 | 63 | 30 | 33 | 0 | 72 |
| 2020 | 16 | 0 | 0 | 31.9% | 31 | 32 | 0 | 55 | 21 | 23 | 0 | 114 |
| 2021 | 17 | 0 | 0 | 26.0% | 29 | 33 | 0 | 55 | 17 | 17 | 0 | 104 |
| 2022 | 17 | 0 | 0 | 32.5% | 29 | 32 | 1 | 57 | 32 | 34 | 1 | 119 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $3,146,000 | $4,666,667 |
| Injury Adjusted | $3,146,000 | $4,666,667 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.